Of these, 872 19% and 945 19.9% were prescribed for administration via enteral tubes; most of which, in both phases, were observed in ICU - 48.0% 419/872 and 67.6% 639/945, respectively.
De esos, fueron prescritos para administración vía sondas enterales 872 19% y 945 19,9%, siendo la mayor parte, en las dos fases, observada en la UTI, 48,0% 419/872 y 67,6% 639/945, respectivamente.
Desses, foram prescritos para administração via sondas enterais 872 19% e 945 19,9%, sendo a maior parte, em ambas as fases, observada na UTI, 48,0% 419/872 e 67,6% 639/945, respectivamente.